1. (2022, October 07). Pfizer and BioNTech Announce Vaccine Candidate against COVID-19 Achieved Success in First Interim Analysis from Phase 3 study. Press Release. Available online: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against.
2. (2022, October 07). Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization. Press Release. Available online: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study.
3. Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants;MacDonald;Vaccine,2015
4. World Health Organization (WHO) (2022, October 07). Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
5. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications;Dube;Expert Rev. Vaccines,2015